Showing results (151-160 of 206) with videos related to

Sort By:
Pageof 21
Blood Cancer Discovery|September 2, 2022
Progenitor Hierarchy of Chronic Myelomonocytic Leukemia Identifies Inflammatory Monocytic-Biased Trajectory Linked to Worse OutcomesMeghan C Ferrall-Fairbanks, Abhishek Dhawan, Brian Johnson, et al.
Blood Advances|April 23, 2021
Oxidized mitochondrial DNA released after inflammasome activation is a disease biomarker for myelodysplastic syndromesGrace A Ward, Kathy L McGraw, Farnoosh Abbas-Aghababazadeh, et al.
British Journal of Haematology|December 12, 2023
TP53 variant allele frequency and therapy-related setting independently predict survival in myelodysplastic syndromes with del(5q)Ayalew Tefferi, Farah Fleti, Onyee Chan, et al.
Blood Advances|September 30, 2021
A geno-clinical decision model for the diagnosis of myelodysplastic syndromesNathan Radakovich, Manja Meggendorfer, Luca Malcovati, et al.
Leukemia|March 22, 2019
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemiaNolwenn Lucas, Matthieu Duchmann, Philippe Rameau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2021
Integrated Human and Murine Clinical Study Establishes Clinical Efficacy of Ruxolitinib in Chronic Myelomonocytic LeukemiaAnthony M Hunter, Hannah Newman, Amy E Dezern, et al.
The Lancet. Haematology|August 4, 2018
Assessment of ASC specks as a putative biomarker of pyroptosis in myelodysplastic syndromes: an observational cohort studyAshley A Basiorka, Kathy L McGraw, Farnoosh Abbas-Aghababazadeh, et al.
Blood|October 15, 2016
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotypeAshley A Basiorka, Kathy L McGraw, Erika A Eksioglu, et al.
International Journal of Molecular Sciences|February 25, 2023
Oxidized Mitochondrial DNA Engages TLR9 to Activate the NLRP3 Inflammasome in Myelodysplastic SyndromesGrace A Ward, Robert P Dalton, Benjamin S Meyer, et al.
Blood|January 28, 2015
An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adultsMichael R Savona, Luca Malcovati, Rami Komrokji, et al.
Pageof 21